Innovative, Articulate, and Easy to Follow: Ocugen Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference Introduction MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and…